InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, plc

KNSA Clue Score67
Fiscal year ends December CIK 0001730430 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Baker Bros. Advisors LP
29 May 2018
Director
Buy indirect
2,700,597
$18.00
$48.61M
Baker Bros. Advisors LP
29 May 2018
Director
Buy indirect
299,403
$18.00
$5.39M
Cormorant Asset Management, LP
29 May 2018
10% owner
Buy indirect
69,444
$18.00
$1.25M
James E Flynn
29 May 2018
10% owner
Buy indirect
235,019
$19.24
$4.52M
James E Flynn
29 May 2018
10% owner
Buy indirect
25,000
$20.91
$522.75K
James E Flynn
29 May 2018
10% owner
Buy indirect
250,000
$19.81
$4.95M
James E Flynn
29 May 2018
10% owner
Buy indirect
333,333
$18.00
$6.00M
Show all 237 transactions →

What was left out

Form 4 filings counted 358
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 205
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 8,216,831
Sales filed before the plan box existed 7
History held since 29 May 2018